Annual Cash & Cash Equivalents
$9.16 M
+$6.90 M+304.37%
December 31, 2023
Summary
- As of February 8, 2025, FBLG annual cash & cash equivalents is $9.16 million, with the most recent change of +$6.90 million (+304.37%) on December 31, 2023.
- During the last 3 years, FBLG annual cash & cash equivalents has risen by +$8.76 million (+2151.35%).
- FBLG annual cash & cash equivalents is now at all-time high.
Performance
FBLG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$7.83 M
+$1.85 M+31.04%
September 30, 2024
Summary
- As of February 8, 2025, FBLG quarterly cash and cash equivalents is $7.83 million, with the most recent change of +$1.85 million (+31.04%) on September 30, 2024.
- Over the past year, FBLG quarterly cash and cash equivalents has stayed the same.
- FBLG quarterly cash and cash equivalents is now -31.21% below its all-time high of $11.38 million, reached on June 1, 2023.
Performance
FBLG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FBLG Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +304.4% | 0.0% |
| 3 y3 years | +2151.3% | 0.0% |
| 5 y5 years | +2151.3% | 0.0% |
FBLG Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2151.3% | -31.2% | +245.4% |
| 5 y | 5-year | at high | +2151.3% | -31.2% | +245.4% |
| alltime | all time | at high | +2151.3% | -31.2% | +245.4% |
FibroBiologics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.83 M(+31.0%) |
| Jun 2024 | - | $5.97 M(-26.8%) |
| Mar 2024 | - | $8.16 M(-11.0%) |
| Dec 2023 | $9.16 M | $9.16 M(-14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $10.77 M(-5.4%) |
| Jun 2023 | - | $11.38 M(+402.1%) |
| Dec 2022 | $2.27 M(+456.8%) | - |
| Dec 2022 | - | $2.27 M |
| Dec 2021 | $407.00 K | - |
FAQ
- What is FibroBiologics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for FibroBiologics?
- What is FibroBiologics annual cash & cash equivalents year-on-year change?
- What is FibroBiologics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for FibroBiologics?
- What is FibroBiologics quarterly cash and cash equivalents year-on-year change?
What is FibroBiologics annual cash & cash equivalents?
The current annual cash & cash equivalents of FBLG is $9.16 M
What is the all time high annual cash & cash equivalents for FibroBiologics?
FibroBiologics all-time high annual cash & cash equivalents is $9.16 M
What is FibroBiologics annual cash & cash equivalents year-on-year change?
Over the past year, FBLG annual cash & cash equivalents has changed by +$6.90 M (+304.37%)
What is FibroBiologics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FBLG is $7.83 M
What is the all time high quarterly cash and cash equivalents for FibroBiologics?
FibroBiologics all-time high quarterly cash and cash equivalents is $11.38 M
What is FibroBiologics quarterly cash and cash equivalents year-on-year change?
Over the past year, FBLG quarterly cash and cash equivalents has changed by $0.00 (0.00%)